Join Us in Advancing Hematology and Oncology Care

 

The Canadian MPN Group is dedicated to improving the diagnosis, treatment, and care of patients with Myeloproliferative Neoplasms (MPNs). We invite organizations specializing in hematology and oncology, including clinical practices, research institutions, pharmaceutical companies, and patient care advocates, to partner with us in our mission. By collaborating, we can enhance the quality of care, foster innovative research, and improve patient outcomes across Canada.

 

Collaborative Efforts for Better Patient Outcomes

 

Partnership with the Canadian MPN Group provides a unique opportunity to contribute to groundbreaking research and patient care initiatives. Our collaborative network brings together leading experts and resources from various fields to address the complex challenges of MPNs. Together, we can develop new diagnostic tools, optimize treatment protocols, and support comprehensive patient care programs. Your organization’s expertise and commitment are vital to making significant advancements in MPN management.

 

Be a Part of the Future of MPN Care

 

We believe that through partnership and collaboration, we can achieve better lives for those affected by MPNs. Your organization can play a pivotal role in this transformative journey. Join us in our efforts to educate, advocate, and support the MPN community. Together, we can make a meaningful difference in the lives of patients and their families. To become a partner, please fill out the form below, and let’s work together to shape the future of hematology and oncology care in Canada.

 

Interact with Pallas

 

Should you have interest in interacting with Pallas, the GPT based assistant trained to support researchers on matters related to MPNs, please submit your request though the form below. Please be sure to include in your request the following: academic/business email; affiliation; the type of activity / project Pallas is planned to provide assistance to; initial and final date of intended use; expression of willingness/ unwillingness to provide feedback on Pallas performance. Please be aware that the authorization to interact with Pallas is personal and individual, is granted under the discretion of the Canadian MPN Group, and may be revoked at anytime.